The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Ozempic Knock Offs Contain Unsafe Substance Banned by FDA, Novo Finds Bloomberg Is BPC 157 Banned? Oral vs. Injectable Forms Explained Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News BPC 157: Experimental Peptide Creates Risk for Athletes